A 65-year-old man (weight 88 kg) requests a refill for "Plavix," but the profile shows clopidogrel. Medical history: ischemic stroke, peripheral artery disease. Allergies: none. Current medications: clopidogrel 75 mg daily, atorvastatin 40 mg nightly, amlodipine 5 mg daily. Labs: platelets 210k/µL (150–400k), SCr 1.0 mg/dL (0.6–1.3). What is the primary indication for clopidogrel's drug class?
- Prevention of platelet aggregation in atherosclerotic disease (antiplatelet therapy) (correct answer)
- Treatment of acute bacterial pneumonia (antibiotic therapy)
- Rapid reversal of opioid overdose (opioid antagonist)
- Chronic suppression of gastric acid secretion via H2 blockade
Explanation: Drug names include generic and brand designations, while therapeutic classes categorize medications based on their mechanism of action and clinical indications. Understanding therapeutic classes is clinically relevant for confirming antiplatelet therapy in atherosclerotic disease prevention. The correct answer, prevention of platelet aggregation in atherosclerotic disease (antiplatelet therapy), represents optimal pharmacist decision-making as it aligns with clopidogrel's (Plavix) use post-stroke. Treatment of acute bacterial pneumonia and rapid reversal of opioid overdose are incorrect as antibiotic and naloxone indications. Chronic suppression of gastric acid is also incorrect because it describes H2 blockers like ranitidine. A clinical pearl is that clopidogrel is a P2Y12 inhibitor often used with aspirin. In similar refill requests, pharmacists should verify adherence and bleeding risks.